Insulin glulisine Subcutaneous and Recombinate recombinant
Determining the interaction of Insulin glulisine Subcutaneous and Recombinate recombinant and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glulisine
Brand name: Apidra, Apidra OptiClik Cartridge, Apidra SoloStar Pen
Synonyms: Insulin glulisine, Insulin Glulisine
Generic Name: antihemophilic factor
Brand name: Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Hemofil-M, Koate-DVI, Monoclate-P, Jivi, Obizur
Synonyms: Recombinate (recombinant), Recombinate
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glulisine Subcutaneous-Recombivax
- Insulin glulisine Subcutaneous-Recombivax HB
- Insulin glulisine Subcutaneous-Recombivax HB Adult
- Insulin glulisine Subcutaneous-Recombivax HB Dialysis Formulation
- Insulin glulisine Subcutaneous-Recombivax HB Pediatric/Adolescent
- Insulin glulisine Subcutaneous-Recort Plus
- Recombinate recombinant-Insulin human inhaled Inhalation
- Recombinate recombinant-Insulin human regular Injection
- Recombinate recombinant-Insulin inhalation
- Recombinate recombinant-Insulin isophane
- Recombinate recombinant-Insulin isophane and insulin regular
- Recombinate recombinant-Insulin lispro